A randomized trial to assess the biological activity of short-term (pre-surgical) fulvestrant 500 mg plus anastrozole versus fulvestrant 500 mg alone or anastrozole alone on primary breast cancer
John F. R. Robertson(University of Nottingham), Julia M.W. Gee(Cardiff University)
Cited by 35